Sergey Gurevich, MD
Cardiovascular Disease · Minneapolis, MNNPI 1578839015
Payments from drug & device makers
Across 85 payments — averaging $101.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Teleflex LLC$2K
- Edwards Lifesciences$558
- Abbott$520
- Medtronic$301
- Heartflow, Inc.$175
- plus $499 from 7 others
What the payments were for
- Consulting fees$3,70043%
- Speaking & faculty fees$1,80021%
- Travel & lodging$4836%
- Food & beverage$2,68231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $4,300 |
| Teleflex LLC | 7 | $2,312 |
| Edwards Lifesciences | 12 | $558 |
| Abbott | 9 | $520 |
| Medtronic | 7 | $301 |
| Heartflow, Inc. | 1 | $175 |
| Biotronik Inc. | 1 | $130 |
| Getinge USA Sales, LLC | 4 | $126 |
| Cardiva Medical, Inc. | 5 | $93 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $72 |
| Terumo Medical Corporation | 1 | $54 |
| Heraeus Medical Components, LLC | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vitalyst$2,500
- TURNPIKE$2,052
- GENERAL - THERAPIES$1,200
- Omnilink Elite vascular stent system$433
- AVVIGO Guidance System$293
- FFRct$175
- MANTA$138
- PK Papyrus$130
- Orsiro Mission$130
- COREVALVE EVOLUT R$125
- Edwards SAPIEN 3 Transcatheter Heart Valve$125
- SAPIEN 3 Ultra RESILIA$105
How this compares
$8,665 in reported general payments places this provider in the 60th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 43 | $31,898 |
| EliquisApixaban | 20 | $26,994 |
| Praluent PenAlirocumab | 16 | $13,547 |
| XareltoRivaroxaban | 11 | $6,370 |
| Atorvastatin Calcium | 105 | $1,343 |
| ClopidogrelClopidogrel Bisulfate | 92 | $1,291 |
| Rosuvastatin Calcium | 62 | $1,110 |
| Metoprolol Succinate | 34 | $778 |
| Ezetimibe | 29 | $712 |
| Carvedilol | 38 | $434 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 27 | $407 |
| Losartan Potassium | 41 | $358 |
| Lisinopril | 46 | $318 |
| Nitroglycerin | 21 | $272 |
| Amlodipine Besylate | 27 | $180 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Minneapolis
- Jeffrey ChambersMinneapolis$3.6M
- Thomas KnickelbineMinneapolis$1.6M
- Tamas AlexyMinneapolis$1.5M
- Joao CavalcanteMinneapolis$1.4M
- Daniel DuprezMinneapolis$1.2M
- Markus MeyerMinneapolis$1.1M
- Thenappan ThenappanMinneapolis$809K
- Mario GoesslMinneapolis$770K
- David Miranda HerreraMinneapolis$760K
- Yader Sandoval PichardoMinneapolis$701K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.